These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


343 related items for PubMed ID: 20979172

  • 21. rs660 polymorphism in Ro52 (SSA1; TRIM21) is a marker for age-dependent tolerance induction and efficiency of alloimmunization in sickle cell disease.
    Tatari-Calderone Z, Minniti CP, Kratovil T, Stojakovic M, Vollmer A, Barjaktarevic I, Zhang E, Hoang A, Luban NL, Vukmanovic S.
    Mol Immunol; 2009 Nov; 47(1):64-70. PubMed ID: 19201475
    [Abstract] [Full Text] [Related]

  • 22. Red blood cell alloimmunization in transfused patients with bone marrow failure syndromes.
    Cohen D, Hartung H, Evans P, Friedman DF, Chou ST.
    Transfusion; 2016 Jun; 56(6):1314-9. PubMed ID: 27080340
    [Abstract] [Full Text] [Related]

  • 23. Comparative study of alloimmunization against red cell antigens in sickle cell disease & thalassaemia major patients on regular red cell transfusion.
    Jariwala K, Mishra K, Ghosh K.
    Indian J Med Res; 2019 Jan; 149(1):34-40. PubMed ID: 31115372
    [Abstract] [Full Text] [Related]

  • 24. Molecular blood typing augments serologic testing and allows for enhanced matching of red blood cells for transfusion in patients with sickle cell disease.
    Wilkinson K, Harris S, Gaur P, Haile A, Armour R, Teramura G, Delaney M.
    Transfusion; 2012 Feb; 52(2):381-8. PubMed ID: 21827505
    [Abstract] [Full Text] [Related]

  • 25. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.
    Miller ST, Kim HY, Weiner DL, Wager CG, Gallagher D, Styles LA, Dampier CD, Roseff SD, Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN).
    Transfusion; 2013 Apr; 53(4):704-9. PubMed ID: 22804353
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.
    Chou ST, Jackson T, Vege S, Smith-Whitley K, Friedman DF, Westhoff CM.
    Blood; 2013 Aug 08; 122(6):1062-71. PubMed ID: 23723452
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Coexistence of autoantibodies and alloantibodies to red blood cells due to blood transfusion.
    Ahrens N, Pruss A, Kähne A, Kiesewetter H, Salama A.
    Transfusion; 2007 May 08; 47(5):813-6. PubMed ID: 17465945
    [Abstract] [Full Text] [Related]

  • 32. Frequency of red cell alloimmunization in patients with sickle cell anemia in an Egyptian referral hospital.
    Aly R, El-sharnoby MR, Hagag AA.
    Transfus Apher Sci; 2012 Dec 08; 47(3):253-7. PubMed ID: 22980915
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Screening for new red blood cell alloantibodies after transfusion in patients with sickle cell disease.
    Rankin A, Darbari D, Campbell A, Webb J, Mo YD, Jacquot C, Delaney M, Luban NLC, Nickel RS.
    Transfusion; 2021 Aug 08; 61(8):2255-2264. PubMed ID: 34002408
    [Abstract] [Full Text] [Related]

  • 35. Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization.
    Tournamille C, Meunier-Costes N, Costes B, Martret J, Barrault A, Gauthier P, Galactéros F, Nzouékou R, Bierling P, Noizat-Pirenne F.
    Transfusion; 2010 Jan 08; 50(1):13-9. PubMed ID: 19778340
    [Abstract] [Full Text] [Related]

  • 36. In search of red blood cells for alloimmunized patients with sickle cell disease.
    Flickinger C.
    Immunohematology; 2006 Jan 08; 22(3):136-42. PubMed ID: 17105363
    [Abstract] [Full Text] [Related]

  • 37. Early occurrence of red blood cell alloimmunization in patients with sickle cell disease.
    Sins JW, Biemond BJ, van den Bersselaar SM, Heijboer H, Rijneveld AW, Cnossen MH, Kerkhoffs JL, van Meurs AH, von Ronnen FB, Zalpuri S, de Rijke YB, Ellen van der Schoot C, de Haas M, van der Bom JG, Fijnvandraat K.
    Am J Hematol; 2016 Aug 08; 91(8):763-9. PubMed ID: 27102719
    [Abstract] [Full Text] [Related]

  • 38. Transfusion medicine in a developing country - alloantibodies to red blood cells in multi-transfused patients in Saudi Arabia.
    Gader AG, Al Ghumlas AK, Al-Momen AK.
    Transfus Apher Sci; 2008 Dec 08; 39(3):199-204. PubMed ID: 18951063
    [Abstract] [Full Text] [Related]

  • 39. Red blood cell extended antigen typing in Omani patients with sickle cell disease to enhance daily transfusion practice.
    Breiki ASA, Kindi SA, Castilho L.
    Immunohematology; 2024 Sep 01; 40(3):93-99. PubMed ID: 39373300
    [Abstract] [Full Text] [Related]

  • 40. Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study.
    Schonewille H, Brand A.
    Br J Haematol; 2005 Apr 01; 129(1):151-6. PubMed ID: 15801967
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 18.